Alexander L.T. Imholz

2.3k citations

37 papers · 1.1k indexed · h-index 17

Nephrology top 0.5%
- Dialysis and Renal Disease Management 21
- Renal function and acid-base balance 5
Emergency Medical Services top 1%
- Central Venous Catheters and Hemodialysis 5
Complementary and Manual Therapy top 5%
Surgery top 10%
Pulmonary and Respiratory Medicine top 10%
- Electrolyte and hormonal disorders 3
Genetics
- Estrogen and related hormone effects 5
Cancer Research
- Breast Cancer Treatment Studies 4
Oncology
- Cancer Risks and Factors 3
- Cancer Treatment and Pharmacology 3

Co-authors: Dirk G. Struijk Raymond T. Krediet L. Arisz Gerardus C.M. Koomen Désirée Zemel G.C.M. Koomen Ben P.M. Imholz Wouter Wieling
Cited by: Nephrology Emergency Medical Services Complementary and Manual Therapy
Partner nations: Netherlands Belgium United Kingdom

In The Last Decade

Alexander L.T. Imholz

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by Alexander L.T. Imholz

Since Specialization

Citations

This map shows the geographic impact of Alexander L.T. Imholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander L.T. Imholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander L.T. Imholz more than expected).

Fields of papers citing papers by Alexander L.T. Imholz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander L.T. Imholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander L.T. Imholz. The network helps show where Alexander L.T. Imholz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alexander L.T. Imholz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexander L.T. Imholz Line = papers co-authored together Alexander L.T. Imholz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial S W M Lammers,Sandra M. E. Geurts,Karlijn Susanna Francisca Maria Hermans,Loes Kooreman,Astrid C P Swinkels,Carolien H. Smorenburg,Maurice J.C. van der Sangen,Judith R. Kroep,A.H. Honkoop,Franchette W.P.J. van den Berkmortel,W Roos,S. Linn,Alexander L.T. Imholz,Ingeborg J. H. Vriens,Vivianne C. G. Tjan‐Heijnen	2025	1
2	Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer Suzan E. H. Detert Oude Weme,Lotte M. G. Hulskotte,Walter L. Vervenne,Alexander L.T. Imholz,R.G.H.M. Cremers,Katja Taxis,Anna K.L. Reyners,Inge R. F. van Berlo‐van de Laar,Frank G. A. Jansman,Guillemette E. Benoist	2023	3
3	The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer S W M Lammers,Sandra M. E. Geurts,Irene E.G. van Hellemond,Astrid C P Swinkels,Carolien H. Smorenburg,Maurice J.C. van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,W Roos,Sabine C. Linn,Alexander L.T. Imholz,Marjolein L. Smidt,Ingeborg J. H. Vriens,Vivianne C. G. Tjan‐Heijnen	2023	4
4	Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial Vivianne C. G. Tjan‐Heijnen,S W M Lammers,Sandra M. E. Geurts,Ingeborg J. H. Vriens,Astrid C P Swinkels,Carolien H. Smorenburg,Maurice J.C. van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,W Roos,Sabine C. Linn,Alexander L.T. Imholz	2023	11
5	Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial Irene E.G. van Hellemond,Carolien H. Smorenburg,Petronella G.M. Peer,Astrid C P Swinkels,Caroline Seynaeve,Maurice J.C. van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,Franchette W.P.J. van den Berkmortel,W Roos,Sabine C. Linn,Alexander L.T. Imholz,Maaike de Boer,Vivianne C. G. Tjan‐Heijnen	2020	4
6	Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study Irene E.G. van Hellemond,Carolien H. Smorenburg,Petronella G.M. Peer,Astrid C P Swinkels,Caroline Seynaeve,Maurice J.C. van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,Franchette W.P.J. van den Berkmortel,Maaike de Boer,W Roos,Sabine C. Linn,Alexander L.T. Imholz,Vivianne C. G. Tjan‐Heijnen	2019	11
7	Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure Irene E.G. van Hellemond,Ingeborg J. H. Vriens,Petronella G.M. Peer,Astrid C P Swinkels,Carolien H. Smorenburg,Caroline Seynaeve,Maurice J.C. van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,Franchette W.P.J. van den Berkmortel,Maaike de Boer,W Roos,Sabine C. Linn,Alexander L.T. Imholz,Vivianne C. G. Tjan‐Heijnen	2018	7
8	Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04) Annelot G.J. van Rossum,Marleen Kok,Erik van Werkhoven,Mark Opdam,Ingrid A.M. Mandjes,A. Elise van Leeuwen – Stok,Harm van Tinteren,Alexander L.T. Imholz,Johanneke E.A. Portielje,Monique M.E.M. Bos,Aart van Bochove,Jelle Wesseling,Emiel J. Rutgers,Sabine C. Linn,Hendrika M. Oosterkamp	2018	10
9	Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure Irene E.G. van Hellemond,Ingeborg J. H. Vriens,Petronella G.M. Peer,Astrid C P Swinkels,Carolien H. Smorenburg,Caroline Seynaeve,Maurice J.C. van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,Franchette W.P.J. van den Berkmortel,Jos Kitzen,Maaike de Boer,W Roos,Sabine C. Linn,Alexander L.T. Imholz,Vivianne C. G. Tjan‐Heijnen	2017	22
10	Anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure. Vivianne C. G. Tjan‐Heijnen,Irene van Hellemond,Ingeborg J. H. Vriens,Petronella G.M. Peer,Astrid C P Swinkels,Carolien H. Smorenburg,Maurice van der Sangen,Judith R. Kroep,Hiltje de Graaf,Aafke H. Honkoop,Frans Erdkamp,Franchette van den Berkmortel,Maaike de Boer,Wilfred de Roos,Sabine C. Linn,Alexander L.T. Imholz,Caroline Seynaeve	2017	1
11	Similarities and Differences between the Effects of Amino Acids and Nitroprusside on Peritoneal Permeability during CAPD Caroline E. Douma,Alexander L.T. Imholz,Dirk G. Struijk,Raymond T. Krediet	1998	2
12	Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD Alexander L.T. Imholz,G.C.M. Koomen,W. J. Voorn,D. G. Struijk,L. Arisz,Raymond T. Krediet	1998	41
13	Impact of Different Dialysis Solutions on Solute and Water Transport Raymond T. Krediet,Caroline E. Douma,Marja M. Ho-dac-Pannekeet,Alexander L.T. Imholz,Désirée Zemel,Machteld M. Zweers,Watske Smit,Dirk G. Struijk	1997	14
14	The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients Marja M. Pannekeet,Alexander L.T. Imholz,Dick G. Struijk,G.C.M. Koomen,Monique J. Langedijk,Natalie Schouten,Rudi de Waart,Johan K. Hiralall,R. T. Krediet	1995	133
15	Clinical Significance and Detection of Individual Differences and Changes in Transperitoneal Transport Raymond T. Krediet,Alexander L.T. Imholz,Désirée Zemel,Dirk G. Struijk,G.C.M. Koomen	1994	2
16	Fluid and solute transport in CAPD patients using ultralow sodium dialysate Alexander L.T. Imholz,Gerardus C.M. Koomen,D. G. Struijk,L. Arisz,R. T. Krediet	1994	70
17	Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD Alexander L.T. Imholz,Gerardus C.M. Koomen,Dirk G. Struijk,L. Arisz,R. T. Krediet	1993	66
18	Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD Alexander L.T. Imholz,Gerardus C.M. Koomen,Dirk G. Struijk,L. Arisz,Raymond T. Krediet	1993	83
19	Use of the Disappearance Rate for the Estimation of Lymphatic Absorption during CAPD Dirk G. Struijk,Alexander L.T. Imholz,R.T. Krediet,G.C.M. Koomen,L. Arisz	1992	3
20	Effects of Tracer, Volume, Osmolarity and Infection on Fluid Kinetics during CAPD Raymond T. Krediet,Alexander L.T. Imholz,Dirk G. Struijk,G.C.M. Koomen,L. Arisz	1992	4

About Alexander L.T. Imholz

Alexander L.T. Imholz is a scholar working on Nephrology, Emergency Medical Services and Complementary and Manual Therapy, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (21 papers), Renal function and acid-base balance (5 papers), Estrogen and related hormone effects (5 papers), Central Venous Catheters and Hemodialysis (5 papers), Breast Cancer Treatment Studies (4 papers), Cancer Risks and Factors (3 papers), Cancer Treatment and Pharmacology (3 papers) and Electrolyte and hormonal disorders (3 papers). The work is most often cited by research in Nephrology (807 citations), Emergency Medical Services (299 citations) and Complementary and Manual Therapy (34 citations). Alexander L.T. Imholz has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Dirk G. Struijk, Raymond T. Krediet, L. Arisz, Gerardus C.M. Koomen, Désirée Zemel, G.C.M. Koomen, Ben P.M. Imholz, Wouter Wieling, Karel H. Wesseling and R. L. H. Sprangers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact